Exagen Inc (XGN)
Healthcare
Diagnostics & Research
4.50 $
-3.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Exagen Inc (XGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.2% of the shares are freely tradable; institutional investors hold 52.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
52.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
28.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
57.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
24Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Balyasny Asset Management LLC | 3.30 | 796,632 | -13.3 | 03/31/2026 |
| Wexford Capital LP | 3.28 | 792,855 | +69.9 | 03/31/2026 |
| Vanguard Group Inc | 3.27 | 790,011 | +7.7 | 12/31/2025 |
| Acadian Asset Management LLC | 2.85 | 689,114 | +266.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.81 | 678,652 | +0.0 | 03/31/2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 2.42 | 585,000 | +134.0 | 03/31/2026 |
| Silvercrest Asset Management Group LLC | 2.23 | 537,870 | -10.0 | 03/31/2026 |
| Kennedy Capital Management Inc | 2.04 | 493,660 | +2.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.12 | 511,952 | +0.0 | 04/30/2026 |
| Kennedy Micro Cap Opportunities | 2.03 | 491,066 | +2.8 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.